Our therapeutic areas and diseases
Haematology
Advancing treatment for rare blood disorders such as haemophilia and paroxysmal nocturnal haemoglobinuria through targeted innovation.
Nephrology
Improving outcomes for patients with rare kidney disorders such as complement 3 glomerulopathy through complement research.
Cardiometabolic
Developing therapies for rare genetic and metabolic diseases, including transthyretin-mediated amyloidosis and hereditary tyrosinaemia type 1.
Immunology
Driving progress in immune-mediated diseases like Still’s disease and cryopyrin-associated periodic syndromes with deep scientific expertise.
Specialty Care
We provide products for the treatment of genetic and metabolic diseases as well as a number of specialist indications.
Our products in United Kingdom and Ireland
Here you will find scientific, educational and promotional content about our products.
Explore more
About Sobi
Sobi is an international biopharmaceutical company focused on rare diseases. We are dedicated to providing access to innovative treatments that transform life for people with rare diseases.
Learn about Sobi and our commitment to transforming the lives of people with rare diseases.
Contact
Get in touch with your local Sobi team for product, medical or educational support.